Header Logo

Connection

CHARLES MINARD to Anilides

Back to Details
This is a "connection" page, showing publications CHARLES MINARD has written about Anilides.
CHARLES MINARD
Connection Strength
0.148
Anilides
  1. A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 08; 65(8):e27077.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.